NCT02507804 A Study to Evaluate a Diary for Patient Reported Outcome Measures (PROMs) Status COMPLETED Phase NA
NCT02502396 Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center Status COMPLETED Phase N/A
NCT02501460 Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors Status COMPLETED Phase NA
NCT02501213 Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC) Status TERMINATED Phase PHASE2
NCT02501174 Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG). Status COMPLETED Phase N/A
NCT02500173 Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy Status TERMINATED Phase N/A
NCT02499861 Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02495376 Reducing Emotional Distress, Enhancing Function and Improving Network Engagement in Adolescent and Young Adult Oncology Status COMPLETED Phase NA
NCT02489799 Utilizing Advance Care Planning Videos to Empower Perioperative Cancer Patients and Families Status COMPLETED Phase NA
NCT02483858 Study of Oral PQR309 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02483247 A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02482415 Effects of a Psycho-educational Intervention for Family Caregivers in Palliative Care Status UNKNOWN Phase NA
NCT02482285 Assessment of Frailty in Elderly Patients With Advanced Cancers Status TERMINATED Phase N/A
NCT02478931 Study of Personalized Cancer Therapy to Determine Response and Toxicity Status RECRUITING Phase N/A
NCT02476552 Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer Status COMPLETED Phase PHASE1
NCT02467361 A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers Status COMPLETED Phase PHASE1